EUROPEAN PRICE CONTROLS NOT SUFFICIENT TO CONTROL DRUG SPENDING WITHOUT HAVING POLICIES IN PLACE TO CONTROL USE, GAO FINDS; EFFECT OF POLICIES ON R&D UNCLEAR
Executive Summary
The price controls used by four European countries have not been sufficient to control drug spending without implementation of other policies to control drug use, the General Accounting Office concludes in a newly released report, entitled Prescription Drugs: Spending Controls in Four European Countries.